Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Highlights that flow alterations combined with genetic alterations of intrinsic EndMT pathways can lead to active clinical manifestation of EFE in adolescence, suggesting new therapies might need to focus on molecular factors influenced by intrinsic and extrinsic stimuli of EndMT.
This is the first description of active clinical manifestation of endocardial fibroelastosis (EFE) and remodeling of the endocardium via endothelial-to-mesenchymal transformation (EndMT) in an adolescent with Shone’s variant hypoplastic left heart complex (HLHC) and a genetic heterozygous ABL1 variant. While EFE has not been typically associated HLHC or Shone’s syndrome, in this patient flow alterations in the left ventricle (LV), combined with genetic alterations of intrinsic EndMT pathways led to active clinical manifestation of EFE in adolescence. This case emphasizes that new therapies for EFE might need to focus on molecular factors influenced by intrinsic and extrinsic stimuli of EndMT.
No takes yet. Share an insight, caveat, or question.
Diaz‐Gil et al. (2022) conducted a case report in Endocardial fibroelastosis in Shone's variant hypoplastic left heart complex (n=1). Surgical resection of EFE and valvuloplasty was evaluated on Clinical and echocardiographic improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: